#USA #Slope #LabConnect #Clinical Trials #Richmond, VA

Slope and LabConnect Enhance Clinical Trial Management

In an exciting development, Slope and LabConnect have taken significant strides in enhancing the operational capabilities of clinical trials through their expanded partnership. Following last year’s successful integration of their Application Programming Interface (API), the two companies have launched multiple new clinical trials in December 2025, with even more set to begin in early 2026. This partnership represents a critical evolution in biospecimen management, primarily aimed at streamlining complex clinical trials.

Revolutionizing Data Integration

Slope, recognized as the premier end-to-end, vendor-agnostic platform for handling biospecimens and lab kits, has partnered with LabConnect, a leader in technology-driven global central laboratory solutions. Their collaboration focuses on unifying the data transfer process in clinical trials, fostering a more integrated and efficient response to clinical needs. By enabling electronic data exchange between the two platforms, they aim to optimize workflows for sponsors, sites, and lab operations.

Jim Munz, the Chief Product and Technology Officer of Slope, emphasized the significant progress made over the past year. "Our transition from API announcement to actual implementation has shown real-world benefits for sponsors launching trials. These clinical studies span various therapeutic areas, showcasing how seamless integration can enhance operational efficiency,” he stated.

Furthermore, LabConnect's CTO, Charles Castano, highlighted that the partnership has allowed for greater biospecimen excellence, by connecting Slope’s site-level inventory and sample management capabilities with LabConnect’s data infrastructure. This integration does not require new hardware, making it easier for sponsors and sites to adapt and adopt these innovative solutions.

Streamlined Processes and Enhanced Control

One of the standout features of this integration is the automated and manual lab kit resupply orders that flow directly into Slope from LabConnect. This seamless data connection enhances visibility and control for sponsors over their site inventory management. Study teams can now set customizable inventory thresholds at both the site and protocol level, creating workflows for order approvals and obtaining real-time monitoring through Slope’s centralized dashboards.

Moreover, inventory shipments from LabConnect to clinical sites are fully digitized. This allows both sites and sponsors to track supply delivery status in real time, ensuring the timely arrival of critical resources. Automatic inventory counts update whenever samples are processed or inventory items expire, which eliminates manual reporting errors and significantly reduces delays from kit collection to lab receipt.

Improving Sample Management and Efficiency

On the sample management front, Slope's integration facilitates the transition from traditional lab manuals to guided workflows tailored for sample collection, processing, and shipment. By electronically capturing subject and sample metadata, the system enables LabConnect to pre-accession samples, which helps in identifying discrepancies before they become problematic, ultimately reducing delays.

Another critical aspect of the partnership is its ability to support more complex operational models, especially those involving home health services or decentralized trial models. For trials that require shipping supplies to multiple locations, the Slope and LabConnect system simplifies inventory management across several sites, further improving logistical efficiency.

Future Developments and Impact

As the collaboration grows, both companies are planning to expand the integration to better support additional sample-tracking workflows, ultimately enhancing the management of biospecimen operations holistically. These features, set for release in early 2026, will further strengthen the partnership's ability to streamline clinical workflows.

With over 2,200 sites already utilizing Slope's platform and a remarkable 98% adoption rate on sponsor-contracted trials, the future looks promising. The Slope and LabConnect partnership is a prime example of how innovative technology can reshape the clinical trial landscape, making trials more efficient, accurate, and responsive to the needs of stakeholders across the healthcare spectrum.

For further details on Slope's innovative solutions in biospecimen lifecycle management, visit slopeclinical.com. To learn more about LabConnect’s services, check out labconnect.com.